OpenAI's venture arm backs Coherence Neuro's $45M seed round for brain implant
Overview
OpenAI Startup Fund and Founders Fund invest in Coherence Neuro's $45 million seed round.
The startup is developing a brain implant to detect and treat brain tumors, and plans to use the funding for a long-term implant clinical trial in patients with glioblastoma, an aggressive brain cancer. Coherence says it has tested the implant in three patients and seven more, according to Wired.
CEO Ben Woodington says OpenAI will not have access to the company's brain or health data.
Written by AI from the articles below · updated Oct 21, 7:19 AM ET
Check the sources:
Article timeline
The articles in this story. Times are ET.
- Wired · AINewsOpenAI's fund backs Coherence Neuro, a brain implant startup for cancer detection
AIOpenAI's venture arm and Founders Fund are investing in Coherence Neuro, which is developing a brain implant to detect and treat cancer, as part of a $45 million seed round. The company says it is testing its implant in three patients and seven more, and plans a glioblastoma clinical trial. CEO Ben Woodington says OpenAI will not have access to its brain or health data.
Heat Trend
Not enough continuous observations to show a trend yet.